Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.53 -0.82 (-5.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cullinan Therapeutics (CGEM) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Cullinan Therapeutics' Depreciation & Amortization (CF) was $79,000 in Q2 2026, up 2.6% from $77,000 a year earlier and unchanged from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cullinan Therapeutics' Depreciation & Amortization (CF) was $316,000 through Jun 30, 2026, up 3.3% year-over-year; for FY2025, it was $311,000, up 1.6% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 38.1% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $306,000 in FY2024 (-1.3%), $310,000 in FY2023 (+233.3%), $93,000 in FY2022 (+75.5%) and $53,000 in FY2021 (-14.5%).
  • Quarterly Depreciation & Amortization (CF) has moved between $9,000 (Q3 2022) and $81,000 (Q2 2023) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for four straight quarters, with growth averaging 1.0% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2023 (growth of 788.9%); the worst was Q3 2022 (a decline of 30.8%).
  • Per Business Quant data, CGEM's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $79,000 (Q1 2026), $79,000 (Q4 2025) and $79,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - 79,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79,000.00
Mar 31, 2026 79,000.00
Dec 31, 2025 79,000.00
Sep 30, 2025 79,000.00
Jun 30, 2025 77,000.00
Mar 31, 2025 76,000.00
Dec 31, 2024 77,000.00
Sep 30, 2024 76,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 76,000.00
Dec 31, 2023 77,000.00
Sep 30, 2023 80,000.00
Jun 30, 2023 81,000.00
Mar 31, 2023 72,000.00
Dec 31, 2022 59,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 12,000.00
Mar 31, 2022 13,000.00
Dec 31, 2021 12,000.00
Sep 30, 2021 13,000.00
API Access

Cullinan Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CGEM&period=max&api_key=YOUR_API_KEY